References
Krumholz HM, Radford MJ, Wang Y et al.National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Co-operative Cardiovascular Project. JAMA 1998;280:623–9.
Inditz MES, Artz MB. Value added to health by pharmacists.Social Science and Medicine 1999;48:647–60.
Bond CA, Raehl CL, Pitterle ME, Franke T. Health care professional staffing, hospital characteristics, and hospital mortality rates. Pharmacotherapy 1999;19(2):130–8.
Bond CA, Raehl CL, Franke T. Clinical Pharmacy Services and hospital mortality rates. Pharmacotherapy 1999;19(5):556–64.
Leape LL, Cullen DJ, Clapp M. Dempsey et al. Pharmacistparticipation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282(3):267–70.
Schumock GT, Meek PD, Ploetz PA, Vermeulen LC and the Publications Committee of the American College of Clinical Pharmacy. Economic evaluations of Clinical Pharmacy Services – 1988–1995. Pharmacotherapy 1996;16(6):1188-1208.
Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinicalpharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol 1999;47:695–700.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Floor‐Schreudering, A., Alós Almiñana, M., Hekster, Y.A. et al. The need for clinical pharmacy. Pharm World Sci 22, 27–30 (2000). https://doi.org/10.1023/A:1008739729849
Issue Date:
DOI: https://doi.org/10.1023/A:1008739729849